Zepp Health Corporation

NYSE:ZEPP Stock Report

Market Cap: US$150.3m

Zepp Health Management

Management criteria checks 2/4

Zepp Health's CEO is Wayne Huang, appointed in Jan 2013, has a tenure of 13.33 years. directly owns 30.09% of the company’s shares, worth $45.23M. The average tenure of the management team and the board of directors is 5.9 years and 5.5 years respectively.

Key information

Wayne Huang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure13.3yrs
CEO ownership30.1%
Management average tenure5.9yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

Seeking Alpha • Apr 19

Zepp Health: A Riskier Bet As Gross Margins Compress (Rating Downgrade)

Summary Zepp Health has shifted from a buy to a neutral rating due to persistent unprofitability and margin concerns. Despite >40% y/y revenue growth in Amazfit, ZEPP faces tough comps and macro headwinds that threaten sustained double-digit expansion. Gross margins remain in the high 30s, ~20 points below Garmin, limiting ZEPP’s scalability and profit potential. With abundant high-quality software bargains available, I see little justification to maintain or add to ZEPP positions. Read the full article on Seeking Alpha
Analysis Article • Jan 08

Investors Aren't Entirely Convinced By Zepp Health Corporation's (NYSE:ZEPP) Revenues

With a price-to-sales (or "P/S") ratio of 2x Zepp Health Corporation ( NYSE:ZEPP ) may be sending bullish signals at...
Analysis Article • Sep 23

Market Participants Recognise Zepp Health Corporation's (NYSE:ZEPP) Revenues Pushing Shares 28% Higher

Despite an already strong run, Zepp Health Corporation ( NYSE:ZEPP ) shares have been powering on, with a gain of 28...
Analysis Article • Aug 24

Just In: One Analyst Has Become A Lot More Bullish On Zepp Health Corporation's (NYSE:ZEPP) Earnings

Zepp Health Corporation ( NYSE:ZEPP ) shareholders will have a reason to smile today, with the covering analyst making...
Narrative Update • Aug 23

GDPR Pressures And AI Health Developments Will Shape Future Markets

Zepp Health's consensus price target has surged, primarily reflecting sharply higher expected revenue growth and a much richer projected valuation multiple, now placing fair value at $60.23. What's in the News Zepp Health issued Q3 2025 revenue guidance of $72–76 million, projecting a 23–35% year-over-year increase from $42.5 million.
Analysis Article • Aug 04

Zepp Health Corporation (NYSE:ZEPP) Soars 336% But It's A Story Of Risk Vs Reward

Zepp Health Corporation ( NYSE:ZEPP ) shareholders have had their patience rewarded with a 336% share price jump in the...
Analysis Article • Apr 18

Investors Give Zepp Health Corporation (NYSE:ZEPP) Shares A 29% Hiding

Zepp Health Corporation ( NYSE:ZEPP ) shares have had a horrible month, losing 29% after a relatively good period...
User avatar
New Narrative • Apr 12

AI-powered T-Rex 3 And Amazfit Releases Will Redefine Future Possibilities

Transition to a high-margin business model and AI-powered product launches likely to enhance profitability and drive significant revenue growth.
Analysis Article • Aug 20

Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry

Zepp Health Corporation ( NYSE:ZEPP ) shareholders are no doubt pleased to see that the share price has bounced 26% in...
Analysis Article • Aug 03

Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Zepp Health fair value estimate is US$0.56 Zepp Health's...
Analysis Article • Apr 17

Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

To the annoyance of some shareholders, Zepp Health Corporation ( NYSE:ZEPP ) shares are down a considerable 27% in the...
Analysis Article • Dec 23

Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%

The Zepp Health Corporation ( NYSE:ZEPP ) share price has done very well over the last month, posting an excellent gain...
Seeking Alpha • Nov 24

Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales

Summary Zepp returned to profitability in the third quarter for the first time since 2021, as its margins jumped with the development of its own Amazfit brand. The company’s shares initially rose sharply after the report, but then fell even more, as investors worried about a big drop in sales of its own-brand products. Zepp’s latest valuation metrics look ridiculously low, including a forward P/E ratio of just 3.1 and a P/S ratio of 0.14. Read the full article on Seeking Alpha
Seeking Alpha • Jul 31

Can Zepp Health Find Its Way Back Up?

Summary Zepp Health has had the most tumultuous two years. The share price plummeted 88%, and revenue is down by almost 50%. At this point, is ZEPP stock worth investing in? Read the full article on Seeking Alpha
Seeking Alpha • Aug 25

Zepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M

Zepp Health press release (NYSE:ZEPP): Q2 Non-GAAP EPADS of -$0.23. Revenue of $165.5M (-39.6% Y/Y). Total units shipped in the second quarter 2022 decreased by 45.2% year-over-year to 6.3M, compared with 11.5M in the second quarter of 2021.  For the third quarter of 2022, the management of the company currently expects: Net revenues to be between RMB1.2 billion and RMB1.5 billion, compared with RMB1.61 billion in the third quarter of 2021 vs. estimated growth of 23.50% Y/Y.
Analysis Article • Aug 12

What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?

Zepp Health Corporation ( NYSE:ZEPP ), might not be a large cap stock, but it saw a decent share price growth in the...

CEO

Wayne Huang (49 yo)

13.3yrs
Tenure

Mr. Huang Wang, also known as Wayne, is founder and serves as the Chairman of board of Directors and Chief Executive Officer of Zepp Health Corporation (formerly known as Huami Corporation) (the “Company”)...

Leadership Team

NamePositionTenureCompensationOwnership
Mike Yan Yeung
COO & Director11.3yrsno data1.05%
$ 1.6m
Meihui Fan
CTO & Director4.8yrsno data2.03%
$ 3.1m
Wang Huang
Founder13.3yrsno data30.09%
$ 45.2m
Leon Cheng Deng
Chief Financial Officer5.6yrsno data0.69%
$ 1.0m
Grace Yujia Zhang
Director of Investor Relationsno datano datano data
Xiaojun Zhang
VP of Human Resources1.7yrsno datano data
Pengtao Yu
Chief Industrial Designer11.6yrsno data0.74%
$ 1.1m
Ramesh Jain
Chief Technical Advisor of Huami AI Research Institute5.9yrsno datano data
5.9yrs
Average Tenure
47.5yo
Average Age

Experienced Management: ZEPP's management team is seasoned and experienced (5.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mike Yan Yeung
COO & Director1.7yrsno data1.05%
$ 1.6m
Meihui Fan
CTO & Director1.7yrsno data2.03%
$ 3.1m
Wang Huang
Founder13.3yrsno data30.09%
$ 45.2m
Bing Xie
Independent Director5.5yrsno datano data
Jimmy Y. Lai
Independent Director8.3yrsno datano data
Hongjiang Zhang
Independent Director8.3yrsno datano data
Sai Wai Lam
Director1.7yrsno datano data
5.5yrs
Average Tenure
54yo
Average Age

Experienced Board: ZEPP's board of directors are considered experienced (5.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/18 15:26
End of Day Share Price 2026/05/15 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zepp Health Corporation is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ang-Chi LinCitigroup Inc
Siddharth RajeevFundamental Research Corp.
Jones KuHaitong International Research Limited